Bronchial reversibility with a short-acting β2-agonist predicts the FEV1 response to administration of a long-acting β2-agonist with inhaled corticosteroids in patients with bronchial asthma

Author：            

Publisher： Spandidos Publications

ISSN： 1792-0981

Source： Experimental and Therapeutic Medicine, Vol.2, Iss.4, 2011-01, pp. : 619-623

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A long-acting β2-adrenergic agonist increases the expression of muscarine cholinergic subtype3 receptors by activating the β2-adrenoceptor cyclic adenosine monophosphate signaling pathway in airway smooth muscle cells

By          

Molecular Medicine Reports, Vol. 11, Iss. 6, 2015-01 ,pp. : 4121-4128

Spandidos Publications

Access to resources Recommend Favorite

Long-term safety of budesonide/formoterol for the treatment of elderly patients with bronchial asthma

By              

Experimental and Therapeutic Medicine, Vol. 7, Iss. 4, 2014-01 ,pp. : 1005-1009

Spandidos Publications

Access to resources Recommend Favorite

Association of dose escalation of octreotide long‐acting release on clinical symptoms and tumor markers and response among patients with neuroendocrine tumors

By  

Cancer Medicine, Vol. 4, Iss. 6, 2015-06 ,pp. : 864-870

John Wiley & Sons Inc

Access to resources Recommend Favorite

Selective β2 adrenergic agonist increases Cx43 and miR-451 expression via cAMP-Epac

By                      

Molecular Medicine Reports, Vol. 9, Iss. 6, 2014-01 ,pp. : 2405-2410

Spandidos Publications

Access to resources Recommend Favorite

Long intergenic noncoding RNA induced by Xray irradiation regulates DNA damage response signaling in the human bronchial epithelial BEAS2B cell line

By  

Oncology Letters, Vol. 9, Iss. 1, 2015-01 ,pp. : 169-176

Spandidos Publications

Access to resources Recommend Favorite